UE LifeSciences Inc. received FDA clearance for its NoTouch BreastScan thermograph that uses two infrared detectors to help spot breast CA. The contactless system is intended for use as an additional modality to mammograms and ultrasound, and does not require manual image interpretation.
Once scanning is complete, the NoTouch BreastScan provides the physician with an automatically produced report that complements other tests in narrowing down the diagnosis.
“NoTouch BreastScan™ does not discriminate dense breast tissue, which is good news for tens of millions of women in America,” said Azad Anand, MD, Radiologist and Director, Long Island Diagnostic Imaging in New York. John Gomes, MD, a leading gynecologist in New York says, “It looks at breast cancer from a physiologic vantage point not visible to anatomic imaging modalities like mammography and ultrasound. So when we combine the information from both sides, we can assess the full picture.
Press release: UE LifeSciences Inc. Announces FDA Clearance for Complementary Breast Cancer Screening Device
Product page: NoTouch BreastScan